Clinical Trial Update: A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 pilot trial of interferon beta-1a for Alzheimer's disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Interferon beta-1a (Interferon beta-1a)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-04-04